Table 2.

Selected clinical studies of novel agents in AL amyloidosis

Selected clinical studies of novel agents in AL amyloidosis
Selected clinical studies of novel agents in AL amyloidosis

BIW, twice weekly bortezomib schedule; Bortez, bortezomib; CR, complete response rate; Cytox, cyclophosphamide; dex, dexamethasone; Len, lenalidomide; mel or M, melphalan; new, untreated patients; NR, not reported; Pom, pomalidomide; QW, weekly bortezomib schedule; RR, response rate; SCT, autologous stem cell transplant; series, retrospective series; Thal, thalidomide

Close Modal

or Create an Account

Close Modal
Close Modal